Cargando…
Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
BACKGROUND: Progressive loss of skeletal muscle, termed muscle wasting, is a hallmark of cancer cachexia and contributes to weakness, reduced quality of life, as well as poor response to therapy. Previous studies have indicated that systemic host inflammatory response regarding tumor development res...
Autores principales: | Huang, Xiu-yan, Huang, Zi-li, Yang, Ju-hong, Xu, Yong-hua, Sun, Jiu-Song, Zheng, Qi, Wei, Chunyao, Song, Wei, Yuan, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791758/ https://www.ncbi.nlm.nih.gov/pubmed/26975989 http://dx.doi.org/10.1186/s13046-016-0317-z |
Ejemplares similares
-
Erratum to: Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016) -
Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
por: Cole, Calvin L., et al.
Publicado: (2021) -
Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020) -
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
por: Masuo, Kenji, et al.
Publicado: (2021) -
IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2023)